Lilia-Celine Lozada
Stock Analyst at JP Morgan
(2.16)
# 2,812
Out of 5,180 analysts
9
Total ratings
50%
Success rate
12.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $22 → $26 | $24.26 | +7.17% | 2 | Feb 6, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $28.26 | +69.85% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $11.20 | +7.14% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $1.20 | +316.67% | 2 | Nov 7, 2025 |
Envista Holdings
Feb 6, 2026
Maintains: Neutral
Price Target: $22 → $26
Current: $24.26
Upside: +7.17%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $28.26
Upside: +69.85%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $11.20
Upside: +7.14%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $1.20
Upside: +316.67%